EBA
Eagle Bay Advisors’s Cardiff Oncology CRDF Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-339
| Closed | -$1.47K | – | 296 |
|
|
2024
Q4 | $1.47K | Hold |
339
| – | – | ﹤0.01% | 915 |
|
|
2024
Q3 | $905 | Hold |
339
| – | – | ﹤0.01% | 1294 |
|
|
2024
Q2 | $753 | Hold |
339
| – | – | ﹤0.01% | 948 |
|
|
2024
Q1 | $1.81K | Hold |
339
| – | – | ﹤0.01% | 888 |
|
|
2023
Q4 | $502 | Hold |
339
| – | – | ﹤0.01% | 801 |
|
|
2023
Q3 | $471 | Hold |
339
| – | – | ﹤0.01% | 818 |
|
|
2023
Q2 | $498 | Hold |
339
| – | – | ﹤0.01% | 812 |
|
|
2023
Q1 | $559 | Hold |
339
| – | – | ﹤0.01% | 861 |
|
|
2022
Q4 | $475 | Hold |
339
| – | – | ﹤0.01% | 871 |
|
|
2022
Q3 | $1K | Hold |
339
| – | – | ﹤0.01% | 808 |
|
|
2022
Q2 | $746 | Buy |
+339
| New | +$746 | ﹤0.01% | 886 |
|
|
2022
Q1 | – | Sell |
-339
| Closed | -$2K | – | 437 |
|
|
2021
Q4 | $2K | Hold |
339
| – | – | ﹤0.01% | 871 |
|
|
2021
Q3 | $2K | Hold |
339
| – | – | ﹤0.01% | 881 |
|
|
2021
Q2 | $3K | Buy |
+339
| New | +$3K | ﹤0.01% | 788 |
|